Clinuvel Pharmaceuticals Ltd: Notice of Annual General Meeting/Proxy Form
Clinuvel Pharmaceuticals Ltd: Change of AGM Time of Meeting
Clinuvel Pharmaceuticals Ltd: Initial Director's Interest Notice - Pearl Grimes
Clinuvel Pharmaceuticals Ltd: Initial Director's Interest Notice - Guy van Dievoet
Clinuvel Pharmaceuticals Ltd: Initial Director's Interest Notice - Matthew Pringle
Clinuvel Pharmaceuticals Ltd: Update - Notification of buy-back - CUV
Clinuvel Pharmaceuticals Ltd: Chair's letter to Shareholders
Clinuvel Pharmaceuticals Ltd: CLINUVEL Board Renewal, Expansion
Clinuvel Pharmaceuticals Ltd: Update - Notification of buy-back - CUV
Clinuvel Pharmaceuticals Ltd: Update - Notification of buy-back - CUV
Clinuvel Pharmaceuticals Ltd: Update - Notification of buy-back - CUV
Clinuvel Pharmaceuticals Ltd: CLINUVEL Investor Webinar
Clinuvel Pharmaceuticals Ltd: Corporate Governance Statement
Clinuvel Pharmaceuticals Ltd: Appendix 4G
Clinuvel Pharmaceuticals Ltd: Investor Presentation
Clinuvel Pharmaceuticals Ltd: CLINUVEL delivers increases in annual revenue, profit
Clinuvel Pharmaceuticals Ltd: Dividend/Distribution - CUV
Clinuvel Pharmaceuticals Ltd: Appendix 4E and Annual Report to Shareholders 2024
Clinuvel Pharmaceuticals Ltd: Ceasing to be a substantial holder
Clinuvel Pharmaceuticals Ltd: Becoming a substantial holder
No Data
No Data